Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — December 2023

Genmab — December 2023

Planlagt Fastgjort Låst Flyttet Genmab
860 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    gentogen
    wrote on sidst redigeret af
    #196

    Sådan set enig, men lige netop "commercially reasonable" kan jo betyde alt muligt

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gentogen
      wrote on sidst redigeret af
      #197

      I øvrigt har jeg tænkt som EL 14:34. Men så meget mere mystisk er det jo, at JNJ reelt har konkurreret imod Genmab ved at "udvikle" Faspro

      1 Reply Last reply
      0
      • royalR Offline
        royalR Offline
        royal
        wrote on sidst redigeret af
        #198

        Farligt at tro at Dara er den hellige gral. Hvis Hexa er så meget bedre end Dara skal JnJ nok tage den.

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #199

          The Lancet Haematology
          @TheLancetHaem
          Won Seog Kim presents data from the EPCORE NHL-5 dose escalation and expansion trial testing the bispecific antibody epcoritamab plus lenalidomide in patients with r/r DLBCL. One DLT (neutropenia) was observed (primary endpoint). ORR was 71.9% and CR was 53.1% #ASH23 https://twitter.com/TheLancetHaem/status/1733924588126666831

          1 Reply Last reply
          0
          • B Offline
            B Offline
            Bullish
            wrote on sidst redigeret af
            #200

            Er epcoritamab studiet en overraskelse, eller var det ventet?

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #201

              Genmab har lovende resultater med kræfthåb i svært behandlelig lymfekræft https://www.proinvestor.com/investornyt/1088770/genmab-har-lovende-resultater-med-kraefthab-i-svaert-behandlelig-lymfekraeft

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #202

                Multiple Myeloma Hub
                @MM_Hub
                CONGRESS | #ASH23 | Efstathios Kastritis
                @uoaofficial
                discusses the safety and efficacy results of daratumumab monotherapy in ND 3B LC AL from the EMN22 trial. 6-month OS rate was 65% and a haematological response in 77.5% of pts -- AL Amyloidosis--
                https://twitter.com/MM_Hub/status/1733959437386215879

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #203

                  https://twitter.com/AngieYong3/status/1733960771619692743

                  1 Reply Last reply
                  0
                  • Legolas23L Offline
                    Legolas23L Offline
                    Legolas23
                    wrote on sidst redigeret af
                    #204

                    Genmas stiger efter gode resultater https://borsen.dk/nyheder/markedsberetninger/bemaerkelsesvaerdige-resultater-fra-genmab-og-et-stort-negativt-pres-paa-c25-exit-aktie?b_source=borsen&b_medium=row_1&b_campaign=news_3

                    1 Reply Last reply
                    0
                    • M Offline
                      M Offline
                      Milito
                      wrote on sidst redigeret af
                      #205

                      Det er desværre bag en betalingsmur Legolas23

                      1 Reply Last reply
                      0
                      • K Offline
                        K Offline
                        Klarussen
                        wrote on sidst redigeret af
                        #206

                        Det er de værste mure der findes

                        1 Reply Last reply
                        0
                        • Don_JoningD Offline
                          Don_JoningD Offline
                          Don_Joning
                          wrote on sidst redigeret af
                          #207

                          Gid mine Genmabber også blev handlet på den platform, hvor "Genmab stiger efter gode resultater"...

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            Riis7
                            wrote on sidst redigeret af
                            #208

                            Ikke meget KYSO i 2023 som genmab aktionærer:_) må håbe 2024 bliver bedre

                            1 Reply Last reply
                            0
                            • T Offline
                              T Offline
                              Teller
                              wrote on sidst redigeret af
                              #209

                              De har styr på deres stoffer hos Genmab 🙂

                              1 Reply Last reply
                              0
                              • T Offline
                                T Offline
                                Teller
                                wrote on sidst redigeret af
                                #210

                                Udviklingsdelen af dem anyway - mon ikke det andet kommer med tiden 🙂

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #211

                                  E L have you found out if posters are published on the ASH website? Or do we need the app? They only say “online”, but I can’t find them.

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #212

                                    the abstracts of the posters are all you will get i think, need to be lucky to find someone posting a picture on twitter...
                                    https://ash.confex.com/ash/2023/webprogram/start.html#srch=words|epcoritamab|method|and|pge|1|byDayany|any|bySessionTypeP|1|bySymposiumany|any|byAudienceany|any

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #213

                                      Ok, præsentation of gen3014 is at 03:00 tomorrow, but it should be published at 18:00 tonight. 9 am San Diego time. So from then we’ll have to scan Twitter.

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #214

                                        the results may need a bit of explanation and context, hopefully we'll get that tuesday... or maybe Helge can interview Plesner 😉

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #215

                                          fantastisk ide;-)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper